aTYR PHARMA (ATYR) Accumulated Depreciation & Amortization (2019 - 2024)
Historic Accumulated Depreciation & Amortization for aTYR PHARMA (ATYR) over the last 6 years, with Q4 2024 value amounting to $4.5 million.
- aTYR PHARMA's Accumulated Depreciation & Amortization fell 170.96% to $4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.5 million, marking a year-over-year decrease of 170.96%. This contributed to the annual value of $4.5 million for FY2024, which is 170.96% down from last year.
- According to the latest figures from Q4 2024, aTYR PHARMA's Accumulated Depreciation & Amortization is $4.5 million, which was down 170.96% from $4.6 million recorded in Q4 2023.
- aTYR PHARMA's 5-year Accumulated Depreciation & Amortization high stood at $6.6 million for Q4 2020, and its period low was $4.5 million during Q4 2024.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $6.2 million (2021), whereas its average is $5.7 million.
- As far as peak fluctuations go, aTYR PHARMA's Accumulated Depreciation & Amortization skyrocketed by 659.8% in 2020, and later plummeted by 2727.42% in 2023.
- Quarter analysis of 5 years shows aTYR PHARMA's Accumulated Depreciation & Amortization stood at $6.6 million in 2020, then decreased by 7.05% to $6.2 million in 2021, then rose by 3.2% to $6.4 million in 2022, then decreased by 27.27% to $4.6 million in 2023, then decreased by 1.71% to $4.5 million in 2024.
- Its Accumulated Depreciation & Amortization was $4.5 million in Q4 2024, compared to $4.6 million in Q4 2023 and $6.4 million in Q4 2022.